Mechanical stimulus is of upmost importance in tissues developmental and regeneration processes as well as in maintaining body homeostasis. Classical physiological reactions encompass an increase of blood vessel diameter upon exposure to high blood pressure, or the expansion of cortical bone after continuous high-impact exercise. At a cellular level, it is well established that extracellular stiffness, topography, and remote magnetic actuation are instructive mechanical signals for stem cell differentiation. Based on this, biomaterials and their properties can be designed to act as true stem cell regulators, eventually leading to important advances in conventional tissue engineering techniques. This review identifies the latest advances and tremendous potential of magnetic actuation within the scope of regenerative medicine and tissue engineering.
Mechanotransduction, magnetic actuation and tissue engineering -connecting the dots Mechanical forces exert epigenetic control in tissue developmental, remodelling, and regeneration processes [1, 2] . The first medical evidence of the role of mechanical forces in tissue remodelling was provided by the German surgeon Jullius Wolff >100 years ago after detailing the influence of mechanical load on bone mass and geometry in his study 'The Law of Bone Transformation' [3] . Striking evidence of the impact of mechanical loading on bone remodelling came from astronauts living under microgravity conditions. Lack of mechanical load led to detrimental effects such as a significant loss of bone mass, higher incidence of cardiovascular disease, and signs of accelerated biological ageing [4] . Increased mechanical load can, in contrast, have positive effects, as is the case for high-performance athletes such as Olympic fencers. These athletes undertake intermittent high-impact activity, leading to expansion of cortical bone, as well as increase of trabecular bone density and muscle mass [5] . Such strengthening is vital for the protection of the body from injuries [6] .
Physiological changes in response to mechanical load are initiated by a process called mechanotransduction, in which cells detect mechanical changes in their microenvironment through specialised machinery and then translate the information into an appropriate biological response. Mechanotransduction is mediated by structural proteins such as integrins and actomyosin fibres, which establish a physical connection between the cell and the microenvironment. When a mechanical stimulus is applied to the cell, the increase in tension is transmitted through the contraction of actomyosin fibres, a process mediated by the small GTPase Rho and Rho-associated protein kinase (ROCK) proteins [7] .
Mechanotransduction is pivotal in tissue homeostasis; however, ageing and disease may impair this physiological process, giving rise to musculoskeletal disorders [8] [9] [10] [11] [12] [13] [14] , in particular, the loss of muscle mass and function, decreased healing capacity, [15] , and osteoporosis [16, 17] . The fact that osteoporosis is aggravated in menopause, during which oestrogen levels are reduced, may in part be explained by the role of oestrogen as a mechanosensitiser hormone [8] . Sustaining physiological mechanotransduction is thus crucial for maintaining tissue homeostasis and preventing musculoskeletal disorders.
An effective strategy for improving or sustaining mechanotransduction is magnetic actuation (see Glossary), which has been available for nearly three decades in the form of FDA-approved pulsed electromagnetic field (PEMF) therapy [18] . Owing to recent progress in nanomedicine and molecular biology, we can begin to understand the signalling pathways involved in mechanotransduction and exploit them with magnetic actuation for a myriad of applications: stem cell differentiation and homing to injury sites, as well as tissue engineering strategies [19] [20] [21] [22] [23] [24] [25] . In tissue engineering, magnetic actuation can allow for better seeding in 3D scaffolds [26] [27] [28] , and can be used in scaffold-free approaches to build tissues bottom-up from mesenchymal stem cells (MSCs) or induced pluripotent stem cells (iPSCs) [29] [30] [31] .
We discuss the fundamentals of mechanotransduction, the potential use of magnetic actuation in stem cell differentiation and in several aspects of tissue engineering, focusing on the musculoskeletal system, given its vulnerability to physical strain, and because musculoskeletal disorders are predicted to rise due to an increase of the ageing population and extension of life expectancy [32, 33] . Understanding mechanotransduction and identifying the potential uses of magnetic actuation will open new and vibrant avenues for musculoskeletal tissue engineering and regenerative medicine strategies.
Box 1. Overview of proteins involved in mechanotransduction
Focal adhesion (FA) signalling, actomyosin contraction, stretchactivated ion channels, and nuclear associated proteins [26] are all important for mechanotransduction ( Figure I ). Of pivotal importance are integrins, transmembrane heterodimers proteins composed of a and b subunits that physically couple the ECM to the cytoskeleton by linker proteins such as talin and vinculin [27] . The cytoskeleton, composed of actin and myosin fibres, physically bridges the ECM or the cell membrane to the nucleus. Although the nucleus is the largest and stiffest organelle in the cell, it is still susceptible to mechanical forces conveyed through the cytoskeleton [28] . In the nucleus, lamins, transcription regulators Yes-associated protein and tafazzin (YAP/TAZ), myocardin-related transcription factor A (MRTF-A) and nuclear factor (NF)-kB all participate in gene regulation triggered by mechanical cues [29, 30] .
Integrins convey forces between inside and outside the cell and activate downstream signalling pathways. This mechanotransduction is made possible by the establishment of large integrin-scaffold protein assemblies called FAs. Besides integrins, cells can perceive external mechanical stimuli through many other proteins such as cadherins, catenins, the components of the cytoskeleton and nucleoskeleton, stretch-activated ion-channels, and growth factor receptors. Similar to integrins, cadherins are transmembrane proteins and important signalling hubs, but instead of linking the ECM to the cell, they mediate cell-cell communication. In classical cadherins, the cytoplasmic motif is linked to b-catenin. However, because b-catenin is also implicated in transcriptional processes, it may be translocated from cadherins to the nucleus in response to intracellular tension, mediated by signalling components such as the small GTPase Rho and ROCK.
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The study of mechanotransduction is a growing area of investigation and has revealed a variety of mechanosensors and signalling models (Box 1).
Extracellular stiffness is probably the best-studied mechanical property that has been investigated in the context of stem cell differentiation [34] [35] [36] (Table 1) . Stem cells interpret changes in stiffness as alterations in the adhesive ligand presentation and this interpretation has a regulatory role in stem cell fate [37] . However, recent findings show that mechanotransduction is not restricted to cell surface receptors and adhesion, but can occur directly through the nucleus via phosphorylation of emerin [38] . In addition to stiffness, stem cell differentiation can be regulated by topographical cues [39] [40] [41] [42] . Integrins also play a critical role in this process by mediating cell adhesion to micro-or nanoscale topographic features, resulting in the contraction of the cytoskeleton and activation of biochemical signalling pathways [43] . In addition to stiffness and topography, other important physical cues such as mechanical loading and shear stress can modulate mechanotransduction. Both mechanical loading and shear stress are important for maintenance of cell phenotype, as well as for directing stem cell fate towards a specific lineage [44] .
Cell tension triggers important biochemical signalling cascades such as the Rho/ROCK and the mitogen-activated protein kinase (MAPK) pathways. The Rho/ROCK pathway has pleiotropic functions, comprising the regulation of cellular contraction, motility, morphology, polarity, and cell division, which are considered fundamental in stem cell specification [7, 45] . The extracellular signal-regulated kinase (ERK) and p38 branches of the MAPK pathway are also activated upon mechanical stress and are critical regulators of stem cell fate [46] [47] [48] . Interestingly, sustained activation of this pathway is responsible for the regrowth of limbs in regenerative competent vertebrates such as salamander [49] .
Harnessing cell behaviour at distance The incorporation of mechanical cues such as stiffness and/ or topography into biomaterials design is certainly driving the fields of regenerative medicine and tissue engineering forward. Nonetheless, the high cell throughput necessary to successfully implement clinical therapies is still challenging [50] . Previous methods relied on biomaterials being in direct contact with cells, but methods that utilise forces applied at a distance, such as the reverse piezoelectric effect and magnetic actuation would be a viable alternative to increase cell throughput [50] . Mechanotransduction protocols based on the reverse piezoelectric effect entail the delivery of nanosinusoidal vibrations (termed 'nanokicking') to stem cells. Conveyance of this force to cells can modulate cell adhesion and phenotype by activating mechanotransduction pathways to drive stem cell specification towards osteoblastogenesis [50] . Nanokicking may disrupt focal adhesions and interfere with signalling through G-proteins, or focal adhesion kinase (FAK) and ERK, which are implicated in the activation of the osteogenic transcription factor runt-related transcription factor (RUNX)2 [50] . Although the reverse piezoelectric effect enables high cell throughput, it is not as versatile as magnetic actuation, nor does it possess the capacity to activate specific mechanotransduction pathways.
Magnetic actuation using magnetic force alone is thought to deform the plasma membrane, thus causing changes in actomyosin tension levels and promoting cytoskeleton reorganisation. Magnetically induced cytoskeletal rearrangements can activate different mechanosensors embedded in the plasma membrane, such as stretch-activated ion channels and integrins [51] , as well as signalling pathways such as the p38/MAPK pathway ( Figure 1A ) [52] . Such changes can also improve cell survival and viability, decrease the amount of apoptotic molecules (e.g., caspases), increase the amount of antiapoptotic molecules (e.g., bcl-2), diminish the expression of pluripotent genes [53] , or accelerate osteoblast differentiation, bone regeneration, and mineralisation [52, 54] . Although these cellular events are mediated by the Rho/ROCK and MAPK mechanotransduction signalling pathways, other pathways such as the AKT/PI3K pathway, which is linked to the regulation of the cell cycle and directly related to cell proliferation, can play an important role.
Selectivity of magnetic-based approaches
Utilising magnetic force with the addition of magnetic particles can allow for additional levels of control over specific mechanosensors and signalling pathways, and therefore, cell fate. Under these circumstances, magnetic actuation has two main components: the magnetic field and the responsive magnetic nanoparticle [55] . The magnetic field can be generated by permanent magnets or magnetic bioreactors that produce an oscillating pulse [55] .
Remote magnetic actuation can be targeted and precise in comparison to techniques requiring direct contact. For example, exposing cells to a substrate with a certain physiological rigidity will deform the entire cell or portions of it indiscriminately, and has little to no control over specific mechanosensors and signalling pathways. In contrast, remote magnetic actuation in combination with magnetic nanoparticles can target individual cells through specific mechanosensors. Targeting is achieved by the functionalisation of a magnetic nanoparticle with ligands that bind to the desired mechanosensor. Exposure to a magnetic field will thus change the conformation of the targeted mechanosensor, either by magnetic twisting ( Figure 1B ) or clustering ( Figure 1C ), activating it and its associated downstream biochemical signalling pathways.
Magnetic particles can be functionalised with a myriad of bioactive agents, such as the integrin recognition motif arginine-glycine-aspartic acid (RGD) peptide, or antibodies to the potassium channel, subfamily K, member 2 (TREK-1). Magnetic actuation of nanoparticles targeted to TREK-1 causes the upregulation of typical skeletal development markers, in particular the transcription factor SRY (sex determining region Y)-box 9, core binding factor a1 (Cbfa1) and osteopontin in vitro, and type I collagen in vivo, whereas actuation of particles targeted to RGD receptors enhance type I and II collagen synthesis both in vitro and in vivo [56] .
Functionalised magnetic nanoparticles can be used in combination with osteogenic medium [57] , cyclic magnetomechanical stimulation [58] , and bone morphogenic protein (BMP)2 to constitute an integrated strategy to promote bone mineralisation [59] .
The combination of magnetic scaffolds with magnetic force represents another valuable contribution of magnetic actuation to the field of regenerative medicine and tissue engineering. Although less selective than magnetically actuated nanoparticles, magnetically actuated scaffolds are valuable for developing proangiogenic scaffolds. The combination of both an oscillating magnetic field and a magnetic scaffold can drive organisation of endothelial cells into vessel-like structures [60] . In cardiac tissue engineering, brief stimulation of cardiac cells (20 min) was enough to activate the AKT pathway, known to be implicated in cell hypertrophy and survival [61] .
Magnetic actuation in the regeneration compartment
The regeneration compartment or stem cell compartment encompasses the injury site where healing takes place. This is a highly complex microenvironment generally composed of stem cells, blood vessels, secreted factors, among many others such as inflammatory cells, tissue-specific cells, and extracellular matrix proteins (ECM) proteins. Endogenous tissue repair benefits from the interplay between these components with an adequate mechanical environment, such as stiffness, topography, and shear stress [62] . Endothelial cells in the regeneration compartment play a pivotal role in tissue regeneration and organogenesis by secreting autocrine and paracrine factors that are critical for healing, and contribute to angiogenesis by becoming the main components of the new blood vessels [63, 64] . Angiogenesis can be stimulated by manipulating integrins through magnetic twisting ( Figure 1B) or the endothelial receptor cell TIE Tyrosine Kinase 2 (TIE2) through magnetic clustering ( Figure 1C ) [65, 66] . Manipulation through magnetic twisting is achieved using magnetic beads functionalised with RGD-peptide sequences to bind endothelial integrins. Application of a magnetic field perpendicular to the magnetic dipole of the bead twists the bead, thus twisting the integrin. As a result, endothelin (ET)-1 gene expression is increased by >100% [66] . Manipulation through clustering is done using magnetic beads functionalised with TIE2 antibodies to target the receptor [65] . Application of a magnetic field clusters the targeted receptors and activates them, resulting in an increase in the tube-length of vessel-like structures [65] .
Haematopoietic stem cells are important sentinels of the immune system and undertake this surveillance via clustering of IgE molecules bound to high-affinity IgE receptors, also known as FceRI. This clustering activates an intracellular calcium response by raising the intracellular calcium levels and releasing histamine [67] . Ageing has deleterious effects on haematopoietic stem cells in the stem cell compartment, thus leading to a condition called immunosenescense; a state consisting in the reduction of the competence of the immune system [67] . Decrease in immunological competence results from the progressive deterioration of innate and adaptive immune responses [68] . Magnetic actuation can be a useful tool to fight immunosenescence by mimicking the action of IgE activity. This can be achieved by using superparamagnetic nanobeads that bind to the receptor and oligomerise, clustering the FceRI receptor upon the application of a magnetic field in a similar manner as described for integrins in endothelial cells [69] .
An important event in regeneration is stem cell retention and differentiation. Indeed, stem cells possess the innate ability to migrate towards the site of injury, driven by specific biochemical and mechanical cues, and to differentiate in situ to promote tissue or organ regeneration. Long-term success of certain surgical procedures still requires adjuvant therapy to enhance cell retention at a specific site. This can be achieved by labelling stem cells with superparamagnetic iron oxide nanoparticles (SPIONs) and applying a magnetic field to further guide their migration to sites requiring increased cell retention [70, 71] (Figure 1D) . Importantly, cell labelling with SPIONs appears not to affect viability, proliferation, or specification of MSCs into adipogenic, chondrogenic, or osteogenic lineages under in vivo conditions [72] . Similar findings were observed in magnetite-labelled neural stem cells [73] .
Magnetic actuation in tissue engineering
Conventional tissue engineering strategies typically utilise a combination of cells and 3D scaffolds to regenerate or repair a portion of injured tissue. These scaffolds are vital for providing physical and mechanical support for the cells, and can also deliver chemical stimuli that boost healing such as BMP2 or basic fibroblast growth factor (bFGF) [74, 75] . However, the regeneration process is driven not only by chemical factors, but by mechanical cues, and this is reflected by a paradigm shift in tissue engineering. Scaffold materials are now designed with specific mechanical cues such as tissue-matching stiffness or anisotropic surfaces, resulting in improved repair and regeneration.
Despite recent improvements in scaffold design, tissue engineering still faces a number of challenges. For example, once a material is implanted in the body, it may undergo significant physical and chemical changes due to protein adsorption [76] and enzymatic degradation [77] , thus skewing the initially designed properties. Other limitations could be poor cell seeding and invasion due to the tortuosity and/or depth of the scaffold, or the implanted material degrading and releasing byproducts that may trigger inflammatory responses [78] . Magnetic actuation could be used to circumvent many of the current limitations of tissue engineering [79] , for example, to improve cell seeding efficacies and invasion into 3D scaffolds, or as part of a scaffold-free strategy to build portions of transplantable tissues, thus bypassing the possible inflammatory response to a scaffold or its degradation byproducts. Magnetically actuated scaffolds enable mechanical stimulation of cells, but also building cell and drug delivery systems on demand. The possibility of selectively activating mechanotransduction pathways to harness stem cell fate [80, 81] , as well as exerting a modulatory effect of the immune system [64] , makes this approach all the more attractive.
Magnetic-assisted tissue engineering (Mag-TE)
Mag-TE involves cell labelling with magnetic particles, which grants them magnetic properties (Figure 2A ). In the presence of proper culturing conditions and with the application of magnetic force, it is possible to build scaffoldfree portions of skin, liver, or muscle tissue in a variety of shapes [82] . As a proof-of-concept, oriented dense muscle sheets, strings, and rings from mouse myoblasts were produced by Mag-TE [83] . Here, cells were labelled with magnetite cationic liposomes and seeded on a low-adhesive 24-well plates with a rotating magnet underneath. Cells were pulled towards the bottom of the plate by magnetic attraction and formed a dense, multilayered sheet-like construct. To produce strings that mimic muscle fibre bundles, the cells were cultured with a steady immobile magnet underneath, leading to linear cell aggregation, giving rise to a string-like 3D tissue construct.
One of the challenges in the construction and maintenance of myoblast sheets and strings is that these structures shrink considerably over longer cell culture periods, and thus must be stretched, aligned, and anchored to retain their shape and properties. A myoblast cell ring can be used to achieve this function [83] . To create such rings, a suspension of myoblast cells is seeded in a low adhesive cell culture plate with a polycarbonate cylinder placed in the centre. Once the cylinder is fixed, a magnet is placed underneath to accumulate the cells on the bottom of the plate. After a few days in culture, the cell layer shrinks and the obtained ring can be removed to be used to anchor cell sheets and strings. In addition to such proof-of-concept studies, Mag-TE has also been assessed in vivo in a bone regeneration model [29] . In this model, human multilayered MSC sheets were produced and implanted in the cranial defect of a nude rat with histological findings showing significant bone growth 14 days post-implantation. This technique has been also used in proangiogenic therapy, where multilayered adipose-derived stem cell sheets and iPSC sheets were generated and engrafted successfully in ischaemic mouse models to promote vascularisation of the hypoxic tissue [30, 31] .
Magnetic-assisted cell seeding (Mag-seeding) One of the classical techniques in tissue engineering involves cell seeding into a porous 3D scaffold, followed by proliferation and differentiation. After acquisition of tissue-like characteristics, where cells are organised in a way resembling the native tissue and displaying markers of it (e.g., osteocalcin and alkaline phosphatase are typical of bone tissue), the construct is implanted at the injury site. Cell seeding and invasion can still be challenging due to the depth and/or tortuosity of 3D scaffolds.
Mag-seeding can overcome this limitation. In this technique, cells are labelled with magnetic particles, placed on top of the scaffold, and then driven to invade the scaffold by magnetic forces from below ( Figure 2B ). Mag-seeding has proven effective in promoting infiltration and distribution of magnetically labelled fibroblasts in poly(lactic-coglycolic acid) (PLGA), collagen, and polystyrene materials [26] [27] [28] . This strategy can be used with great precision, enabling distribution of cells with a high degree of spatial resolution. In this respect, magnetic tweezers are successfully used to probe and position labelled cells, allowing the seeding cells at high densities, as well as finely-tuned spatial organisation inside the construct [84] .
Magnetic biomaterials
Soft and hard materials are susceptible to acquiring magnetic properties through the incorporation of magnetic iron oxide particles, as demonstrated in the development of magnetic hydrogels [85] , magnetic bioactive glasses [86] magnetic blends of poly(caprolactone) (PCL)/hydroxyapatite [86] , magnetic nanofibrous hydroxyapatite poly-lactide acid (PLA) [87] ,and magnetic PCL [88] . The methods for incorporation of magnetic particles in biomaterials include doping, blending, in situ precipitation, and the 'graftingonto' method [89] . For the purposes of tissue engineering, a material is considered to have satisfactory magnetic properties if magnetic saturation values are above 0.049 emu/g [90] .
Magnetic biomaterials in combination with magnetic force provide numerous benefits unavailable to other methods and materials [55] . This approach permits the construction of magnetically actuated scaffolds with angiogenic [60] and osteogenic [88] potential, both of which are important for bone regeneration. Although the biophysical and biochemical mechanisms underlying this response remain elusive, it is postulated that magnetisation induces local deformation of the scaffold, which in turns mechanically stimulates cells [61] ( Figure 2C ). Magnetically actuated scaffolds also provide a platform for cell and drug delivery on demand [85] . Typically, this is performed with ferromagnetic hydrogels (ferrogels), consisting of hydrogels incorporating ferromagnetic particles and further enriched with growth factors and/or cells ( Figure 2D ). Upon the application of a magnetic field, the hydrogel contracts, expelling the biomolecules and/or cells contained within it ( Figure 2D ) [85] . If the ferrogel is placed at an injury site, it can act as a potent delivery vehicle. Alternatively to release on-demand, growth factors can be covalently conjugated to the ferromagnetic particles to be delivered in a sustained manner [91] . For example, bFGF-conjugated particles embedded in fibrin hydrogels were found to encourage the proliferation and differentiation of cells to be used in the regeneration of spinal cord injuries, as compared to hydrogels containing free bFGF [91] .
Magnetic materials are often obtained through the incorporation with iron oxide nanoparticles and although iron is an essential mineral of our body, the size of such particles raises a number of safety concerns with respect to their use in medicine, such as cytotoxicity, bioaccumulation, and inflammation [92] . However, such concerns have been dissipated by a number of in vivo tests demonstrating that magnetic nanofibrous scaffolds of PCL implanted subcutaneously [93] and magnetic hydroxyapatite/collagen scaffolds implanted in rabbit distal femoral epiphysis and tibial mid-diaphysis did not appear to cause inflammation [94] . Furthermore, magnetic hydroxyapatite, prepared with different ratios of magnetic particles, when implanted in rabbit bone critical size defects produced in the condyle region, had similar biocompatibility to hydroxyapatite alone [95] . Indeed, it has been observed that granting magnetic properties to biomaterials can lead to a significant increase in cell proliferation [95, 96] . The mechanisms underlying this stimulation still need to be elucidated.
These results, as well as the fact that uptake of SPIONs has no impact on viability or differentiation potential in a diverse array of cells [72, 73] , are good indicators of the safety of magnetically actuated materials. However, longterm in vivo tests must be undertaken before drawing further conclusions.
Concluding remarks and future perspectives
Magnetic actuation, especially in combination with magnetic nanoparticles, is a valuable tool for harnessing stem cell guidance, retention, and differentiation. This technology is also promising in promoting the occurrence of key cellular events within the regeneration compartment, such as angiogenesis, and in ameliorating competence of the immune system.
Other important contributions of magnetic actuation can be found in tissue engineering, where this technology is being effectively used in building scaffold-free tissue constructs, enhancing cell seeding efficacies in 3D scaffolds, and interestingly in magnetic responsive materials.
Indeed, another approach we strongly consider for the future lies in magnetically actuated scaffolds. These could be prevascularised and implanted, for example, in a bone defect and further exposed to a magnetic field to mechanically stimulate cells within the regeneration compartment. To conclude, we anticipate that magnetically based approaches will bring remarkable progress to regenerative medicine and will help improve the treatment efficacy of musculoskeletal disorders and fight healing constraints (Box 2).
Box 2. Outstanding questions
Given the complexity of the translational process from the bench to the bedside, how long will we have to wait to benefit from patient tailored mechanotherapies? Can we build standardised stem cell differentiation protocols based on magnetic actuation? What is the overall impact of magnetic actuation within the regeneration compartment? Functional multilayered iPSCs sheets were constructed for angiogenic therapy: what other development can we expect? Can selective mechanotransduction strategies based on magnetic twisting and clustering help implementing and expanding the use of MSCs and iPSCs in tissue engineering and regenerative medicine?
